Perilla seed oil in combination with nobiletin-rich ponkan powder enhances cognitive function in healthy elderly Japanese individuals: a possible supplement for brain health in the elderly.
- 2022-03-07
- Food & function 13(5)
- Michio Hashimoto
- Kentaro Matsuzaki
- Koji Maruyama
- Shahdat Hossain
- Eri Sumiyoshi
- Harumi Wakatsuki
- Setsushi Kato
- Miho Ohno
- Yoko Tanabe
- Yoko Kuroda
- Shuhei Yamaguchi
- Koji Kajima
- Yasushi Ohizumi
- Osamu Shido
- PubMed: 35171190
- DOI: 10.1039/d1fo03508h
Study Design
- Type
- Randomized Controlled Trial (RCT)
- Population
- 49 healthy elderly Japanese individuals
- Methods
- 12-month randomized, double-blind, parallel-armed study; PO group received 1.47 mL PO daily, POPP group received 1.47 mL PO and 1.12 g ponkan powder daily
- Blinding
- Double-blind
- Duration
- 12 months
- Rigorous Journal
Perilla (Perilla frutescens) seed oil (PO), rich in α-linolenic acid (ALA), can improve cognitive function in healthy elderly Japanese people. Here, supplements containing either PO alone or PO with nobiletin-rich air-dried immature ponkan powder were examined for their effects on cognitive function in 49 healthy elderly Japanese individuals. Patients were enrolled in a 12-month randomized, double-blind, parallel-armed study. Randomized participants in the PO group received soft gelatin capsules containing 1.47 mL (0.88 g of ALA) of PO daily, and those in the PO + ponkan powder (POPP) group received soft gelatin capsules containing both 1.47 mL of PO and 1.12 g ponkan powder (2.91 mg of nobiletin) daily. At the end of intervention, the POPP group showed significantly higher cognitive index scores than the PO group. The pro-cognitive effects of POPP treatment were accompanied by increases in ALA and docosahexaenoic acid levels in red blood cell plasma membranes, serum brain-derived neurotropic factor (BDNF) levels, and biological antioxidant potential. We demonstrate that 12-month intervention with POPP enhances serum BDNF and antioxidant potential, and may improve age-related cognitive impairment in healthy elderly people by increasing red blood cell ω-3 fatty acid levels. Clinical Trial Registry, UMIN000040863.
Research Insights
the POPP group showed significantly higher cognitive index scores than the PO group
- Effect
- Neutral
- Effect size
- Small
- Dose
- 1.47 mL (0.88 g of ALA) daily